Interleukin-17A promotes cigarette smoke-induced lung inflammation and damage

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1027112

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Emphysema is a major global health problem and has been predicted to become the third largest cause of death in the world by 2020. Cigarette smoking is the major cause of emphysema and accounts for more than 95% of cases in industrialized countries. Cigarette smoke triggers cells in the lung to release substances which cause inflammation and "eat away" lung tissue. The aim of this project is to identify therapies to prevent and treat emphysema.

Funded Activity Details

Start Date: 01-01-2012

End Date: 01-01-2014

Funding Scheme: Project Grants

Funding Amount: $650,590.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Respiratory Diseases

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

alveolar macrophages | animal model | cell biology | chronic obstructive pulmonary disease (COPD) | cigarette smoking | cytokines | inflammation | neutrophils | oxidative stress | smoking-related diseases

Related Links